The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
"More than half of those who identified as atheist before the experience no longer identified as atheist afterwards," one ...
Patterns and trends in incidence, survival, and treatment among patients with early-onset lung cancer in the U.S.: A population-based study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
One in 20 U.S. adults in 2023 reported having suicidal thoughts over the past year, researchers detailed in Morbidity and Mortality Weekly Report (MMWR). Another MMWR found that 15% of U.S. adults ...
A Swiss Psychiatrist is offering LSD to patients to combat their fears. July 27, 2009 — -- Nothing's happening, Udo Schulz thought to himself with quiet regret. I must have been given the placebo ...
A team of scientists in California has tweaked the hallucinogenic drug LSD to make it usable to treat schizophrenia and other neuropsychiatric and neurodegenerative diseases. According to the ...
Sept. 4 (UPI) --A study of a pharmaceutical form of the psychedelic drug lysergic acid diethylamide suggests it might relieve anxiety symptoms for up to three months. The results of a preliminary ...
A single dose of an investigational lysergic acid diethylamide (LSD)-based medication known as MM120 (lysergide D-tartrate, Mind Medicine Inc [MindMed]) was associated with a rapid and significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback